The “Exosome Therapeutics Market, 2022-2040” report features an extensive study on the current market landscape, offering an informed opinion on the likely evolution of the exosome therapies in the treatment of various diseases.

Given the potential of novel antibody therapies in the treatment of oncological disorders, there is a growing interest in evaluating such therapy candidates against other life-threatening disease indications as well

The recent rise in the incidence of the monkeypox disease, also known as Mpox, has compelled both industry players and regional government authorities to undertake active initiatives in order to control the spread of the disease